IgE May Predict Response to Omalizumab in Patients With CSU
Baseline levels of IgE may serve as a predictor of response to omalizumab in patients with chronic...
Read More
Spotlight
Clinical Phenotypes Indicate Lack of Therapeutic Response in CSU
In chronic spontaneous urticaria (CSU), the identification of clinical phenotypes enables early...
Read More
The Advantage of Complete Response to Treatment in CSU Patients
The following is a summary of “Benefit of Complete Response to Treatment in Patients With...
Read More
Complete Treatment Response Benefits Patients With CSU
For patients with chronic spontaneous urticaria (CSU), disease management is strongly associated...
Read More
Even With Delay, Surgery Improves Survival in Early NSCLC Versus Stereotactic Radiation
Surgery was superior to stereotactic radiation for early non-small cell lung cancer, even in the...
Read More
Investigational and Existing Medicine for Refractory CSU
The following is the summary of “Existing and Investigational Medications for Refractory Chronic...
Read MoreAnalyzing SEER Medicare Data for eNSCLC Patients
The following is the summary of “Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data” published in the December 2022 issue of Lung Cancer by West, et al. As...
Read More
Survival and Treatment Patterns of Early-stage NSCLC Patients with Locoregional Recurrence
The following is the summary of “Treatment patterns and survival of patients with locoregional...
Read More
Wedge Resections & Underutilization of Adv Chemotherapy Linked with Non-examination of LN in eNSCLC
The following is the summary of “946P – Non-examination of lymph nodes (LN) in early-stage...
Read More
Increased SBRT in eNSCLC Reduces Racial Disparities & Mortality
For patients with early-stage non-small cell lung cancer (eNSCLC), increased use of stereotactic...
Read More
Mobile Phone Call Reminders Improve Compliance With Iron Supplementation
In antenatal women with iron deficiency anemia, mobile phone call reminders—along with standard...
Read More
Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency
Iron deficiency is a significant comorbidity of heart failure (HF), defined as the inability of...
Read More
Incidence, Treatment and Clinical Impact of Iron Deficiency in Chronic Heart Failure: A Longitudinal Analysis
In patients with heart failure (HF), iron deficiency (ID) is a well-recognized therapeutic target;...
Read More
SBRT Utilization Associated With Improved Early-Stage NSCLC Survival and Reduced Disparities
The following is the summary of “Increased Utilization of Stereotactic Body Radiotherapy is...
Read More
Efficacy of EGFR-Tyrosine Kinase Inhibitors and Potential Treatment Strategy Affected by TP53 Mutations
The following is the summary of “Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor...
Read More
Comparison of Oral Iron and Injection Ferric Carboxymaltose to Treat IDA During Pregnancy
The following is a summary of “A Randomised Controlled Trial to Compare Injection Ferric...
Read More
Managing Iron Deficiency Anemia In Pregnancy with Ferric Carboxymaltose
The following is a summary of “Ferric Carboxymaltose in the Management of Iron Deficiency...
Read More
Iron Deficiency Anemia: Prevalence and Reference Range of CBC, Reticulocyte Parameters
The following is a summary of “Prevalence of Iron Deficiency Anemia and Reference Range of...
Read More
Lymphoma eBook
Focus on Lymphoma 2022.indd
Read More